Simultaneous analysis of hemoglobin adducts of acrylamide and glycidamide by gas chromatography-mass spectrometry

被引:48
作者
Pérez, HL
Cheong, HK
Yang, JS
Osterman-Golkar, S
机构
[1] Stockholm Univ, Dept Mol Genome Res, SE-10691 Stockholm, Sweden
[2] Dongguk Univ, Coll Med, Dept Prevent Med, Kyongju 780714, South Korea
[3] Korea Ind Safety Corp, Ind Hlth Res Inst, Inchon, South Korea
关键词
D O I
10.1006/abio.1999.4267
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Acrylamide (AA) is a carcinogen in experimental animals. Glycidamide (GA), formed by metabolic epoxidation of AA, is believed to be responsible for the carcinogenicity of AA. Occupational exposure to AA has been assessed earlier by measurement of its adducts with N-terminal valine in hemoglobin. A background of AA adducts [N-(2-carbamoylethyl) valine (AAVal), about 30 pmol/g globin] was found in individuals without known exposure to the compound. The method previously available for adducts of GA only allowed analysis of samples from highly exposed individuals and showed similar levels of AAVal and adducts of GA [N-(2-hydroxy-2-carbamoylethyl)valine (GAVal)]. We have developed a sensitive method for simultaneous quantification of adducts of GA and AA, which is suitable down to low exposure levels. The method is based on the so-called modified Edman method, where globin is reacted with pentafluorophenyl isothiocyanate under neutral conditions, The valine adducts are then extracted in the form of pentafluorophenylthiohydantoin (PFPTH) derivatives, The analytical procedure included reaction of the PFPTH derivatives with acetic anhydride in order to protect the hydroxyl group of GAVal, The PFPTH derivatives of AAVal and GAVal were analyzed by gas chromatography/tandem mass spectrometry, (H-2(2))AAVal-PFPTH was used as the internal standard. The method was applied to samples from 11 workers at an AA production plant, 1 nonexposed nonsmoker, and a few participants of a smoking cessation program. AAVal levels were in the range 27-1854 pmol/g globin, Recorded levels of GAVal were 3-12% of those of AAVal, suggesting that previous measurements of GAVal overestimate GAVal at low levels Of exposure to AA. (C) 1999 Academic Press.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 15 条
[1]   Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers [J].
Bergmark, E .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) :78-84
[2]   DETERMINATION OF HEMOGLOBIN ADDUCTS IN HUMANS OCCUPATIONALLY EXPOSED TO ACRYLAMIDE [J].
BERGMARK, E ;
CALLEMAN, CJ ;
HE, FS ;
COSTA, LG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 120 (01) :45-54
[3]   FORMATION OF HEMOGLOBIN ADDUCTS OF ACRYLAMIDE AND ITS EPOXIDE METABOLITE GLYCIDAMIDE IN THE RAT [J].
BERGMARK, E ;
CALLEMAN, CJ ;
COSTA, LG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 111 (02) :352-363
[4]   RELATIONSHIPS BETWEEN BIOMARKERS OF EXPOSURE AND NEUROLOGICAL EFFECTS IN A GROUP OF WORKERS EXPOSED TO ACRYLAMIDE [J].
CALLEMAN, CJ ;
WU, Y ;
HE, F ;
TIAN, G ;
BERGMARK, E ;
ZHANG, S ;
DENG, H ;
WANG, Y ;
CROFTON, KM ;
FENNELL, T ;
COSTA, LG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 126 (02) :361-371
[5]   ACRYLAMIDE - A REVIEW OF ITS GENOTOXICITY AND AN ASSESSMENT OF HERITABLE GENETIC RISK [J].
DEARFIELD, KL ;
DOUGLAS, GR ;
EHLING, UH ;
MOORE, MM ;
SEGA, GA ;
BRUSICK, DJ .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 330 (1-2) :71-99
[6]  
IARC, 1995, IARC MON, V60, P389
[7]   Biomonitoring of epichlorohydrin by hemoglobin adducts [J].
Landin, HH ;
OstermanGolkar, S ;
Zorcec, V ;
Tornqvist, M .
ANALYTICAL BIOCHEMISTRY, 1996, 240 (01) :1-6
[8]  
MEIENHOFER J, 1979, INT J PEPT PROT RES, V13, P35
[9]   MODIFIED EDMAN DEGRADATION APPLIED TO HEMOGLOBIN FOR MONITORING OCCUPATIONAL EXPOSURE TO ALKYLATING-AGENTS [J].
MOWRER, J ;
TORNQVIST, M ;
JENSEN, S ;
EHRENBERG, L .
TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY, 1986, 11 (03) :215-231
[10]   EVALUATION OF GENETIC RISKS OF ALKYLATING-AGENTS .2. HEMOGLOBIN AS A DOSE MONITOR [J].
OSTERMANGOLKAR, S ;
EHRENBERG, L ;
SEGERBACK, D ;
HALLSTROM, I .
MUTATION RESEARCH, 1976, 34 (01) :1-10